Gabapentin Tablet
Product Images NDC 71335-3143

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-3143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clcr (Equation)

Clcr (Equation)
This text provides formulas to calculate creatinine clearance (CLCr) for both male and female patients. It includes the necessary information about age, weight, gender-specific correction factor, and serum creatinine levels for the calculation. The formula involves multiplication and adjustment factors for female patients.*
FDA Label Image

Figure-1 (Figure1)

Figure-1 (Figure1)
This text provides a figure showing the weekly mean pain scores of observed cases in the ITT population for Study 1. The graph includes data points for gabapentin at 3500 mg, with the mean pain scores observed over a series of weeks.*
FDA Label Image

Figure-2 (Figure2)

FDA Label Image

Figure-3 (Figure3)

Figure-3 (Figure3)
Description: The text shows the proportion of responders in controlled Postherpetic Neuralgia (PHN) studies, with patients experiencing more than 50% reduction in pain scores. Study 1 revealed a 20% response rate for patients receiving GBP 1800, while Study 2 showed a response rate of 5% for patients on placebo (PBO) and less than 1% for patients receiving GBP 2400.*
FDA Label Image

Figure-4 (Figure4)

Figure-4 (Figure4)
This information presents the Responder Rate of patients receiving Gabapentin as compared to a placebo, based on different doses in Adjunctive Therapy Studies for patients over 12 years old with Partial Seizures. The data is shown in a figure with percentages and daily doses of 600, 900, 1200, and 1800 mg. The figure includes studies labeled as Study a, Study b, and Study c.*
FDA Label Image

Label (Lbl713353143)

Label (Lbl713353143)
The text outlines the details of Gabapentin Tablets, USP containing 600 mg of Gabapentin per film-coated tablet. It includes storage instructions, dosage information, and a reference to prescribing information available in the package insert. The medication is to be dispensed by a pharmacist accompanied by a medication guide for each patient, with a reminder to keep it out of reach of children.*
FDA Label Image

Struc (Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.